Add BrightSurf on Google Email

B-cell lymphoma: Cause of high-risk disease discovered

A new study has identified molecular tumor characteristics that distinguish between different subtypes of diffuse large B-cell lymphoma (DLBCL). The findings suggest that tumors from high-risk patients, referred to as PG4 proteogenotype, are characterized by specific genetic mutations and protein patterns. These characteristics can hel...

SourceGoethe University Frankfurt·JournalCancer Cell·TypeExperimental study·DateJul 3, 2026

How plants regulate their protein balance

A specific protein complex regulates protein balance in plants, influencing their response to environmental stress. Researchers discovered that this process, known as N-terminal acetylation, maintains the stability of the plant proteome by controlling protein degradation and recycling.

SourceHeidelberg University·JournalNature Communications·DateApr 13, 2026

First “protein map” of neurons that initiate pain

Researchers have created a high-resolution molecular map of specific sensory neurons that trigger pain, revealing two subtypes of nociceptors with distinct functional components. The study provides insights into the molecular mechanisms of chronic inflammatory pain and identifies potential new drug targets using Deep Visual Proteomics.

SourceMax Delbrück Center for Molecular Medicine in the Helmholtz Association·JournalNature Communications·TypeExperimental study·DateApr 13, 2026

Boosting the cell’s own cleanup

Researchers have identified a new class of small molecules that boost the cell's natural recycling machinery to destroy an immune-modulating enzyme called IDO1. This approach takes a bolder approach than traditional drug design, eliminating disease-causing proteins altogether and opening up new possibilities for cancer treatment.

SourceCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences·JournalNature Chemistry·TypeExperimental study·DateJan 7, 2026

DGIST core protein resources center’s research team discovers hazards of “protein absorbative microplastics” to brain cell function

A study by DGIST researchers reveals that protein-absorptive microplastics disrupt brain cell functions and induce inflammatory responses. The research team used proteomics analysis to examine how microplastics bind to proteins and alter cellular functions.

SourceDGIST (Daegu Gyeongbuk Institute of Science and Technology)·JournalEnvironmental Science & Technology·DateAug 14, 2025

Predicting kidney disease trajectories with a simple blood test

Researchers developed a serum proteomics-based prediction model to identify biomarkers involved in ADPKD progression. The study identified 29 proteins linked to immune system, fat transport, and metabolism, which can predict kidney function decline rate. This breakthrough could lead to more accurate and earlier diagnosis of ADPKD.

SourceUniversity of Cologne·JournalNature Communications·TypeExperimental study·DateJul 21, 2025

Disrupting malaria’s inner balance: Targeting parasite’s protein control system could be key to innovative treatments

Researchers discovered a potential vulnerability in P. falciparum by inducing protein aggregation, leading to reduced parasite growth. The study may lead to novel antimalarial strategies targeting the parasite's internal protein folding machinery.

SourceInstitute for Bioengineering of Catalonia (IBEC)·JournalFrontiers in Cellular and Infection Microbiology·TypeExperimental study·DateMay 30, 2025

Newly discovered ‘molecular fingerprints’ could transform diabetes treatment and diagnosis

Researchers have uncovered unique molecular fingerprints for insulin sensitivity, challenging traditional binary classification of people with type 2 diabetes. These signatures can help identify individuals at risk earlier than current methods, paving the way for personalized treatments and precision medicine.

Six proteins implicated in early-onset preeclampsia

A study published in ACS' Journal of Proteome Research found six proteins that could be used as targets for diagnosing and treating early-onset preeclampsia. These proteins may be linked to cardiovascular complications or the estrogen cycle, suggesting a promising first step toward improved detection and treatment.

SourceAmerican Chemical Society·JournalJournal of Proteome Research·DateOct 14, 2024

Toronto researchers devise new way to find proteins for targeted treatment of disease

Researchers at the University of Toronto and Sinai Health have created a new platform to identify proteins that can be co-opted to control the stability of other proteins. The study identified over 600 new effector proteins that could be used therapeutically, including those that can efficiently degrade or stabilize target proteins.

SourceUniversity of Toronto·JournalNature·TypeExperimental study·DateMar 22, 2024

Systemic changes induced by ASCOT in plasma proteome of women with impaired ovarian reserves

Researchers found that ASCOT reverses some age-related protein expression changes, enriching processes related to the complement cascade and immune system in patients with poor ovarian response. In contrast, patients with premature ovarian insufficiency showed enrichment in responses to oxygen-containing compounds and growth hormones.

SourceImpact Journals LLC·JournalAging-US·TypeExperimental study·DateJan 9, 2024

Lost in translation: How “risky” amino acids abort elongation in protein synthesis

A recent study published in Nature Communications reveals that nascent peptide chains with N-terminal sequences rich in aspartic acid or glutamic acid can lead to abortion of translation in eukaryotic cells through intrinsic ribosome destabilization (IRD). This phenomenon is associated with biased amino acid usage in proteomes, where t...

SourceTokyo Institute of Technology·JournalNature Communications·TypeExperimental study·DateJan 5, 2023

Novel acute myeloid leukemia subtypes identified

Scientists at the Max Planck Institute of Biochemistry have discovered a new subtype of acute myeloid leukemia (AML) characterized by high amounts of mitochondrial proteins and altered mitochondrial metabolism. This subtype, called Mito-AML, shows clinical resistance to chemotherapy and can be effectively combated with inhibitors again...

SourceMax-Planck-Gesellschaft·JournalCancer Cell·DateMar 7, 2022

Shining light on the dark proteome

Researchers are developing new methods to identify and characterize unknown proteins, including those with multiple forms and modifications. Artificial intelligence-based tools are also helping predict protein structures and functions, providing clues to their roles in health and disease.

SourceAmerican Chemical Society·JournalChemical & Engineering News·DateJan 26, 2022

Hard times are coming: Brain tissue stiffness is crucial for neurogenesis

Researchers defined the proteome of neural stem cell niches and compared it to other brain regions to identify key regulators for neurogenesis. The findings suggest that the unique niche environment allows neurogenesis in the adult mammalian brain, and may contribute to the stiffness of neural stem cell niches.

'Big data' for life sciences

A new co-regulation map of the human proteome has been created, enabling the prediction and assignment of functions to uncharacterized human proteins. The map reveals unexpected partnerships between proteins, including peroxisomal membrane protein PEX11β with mitochondrial respiration factors.

SourceUniversity of Exeter·JournalNature Biotechnology·DateNov 5, 2019

Nutmeg's hidden power: Helping the liver

Researchers have discovered how nutmeg helps protect the liver, using a mouse animal model of liver toxicity. The spice was shown to restore healthy levels of lipids and acylcarnitines, and a specific compound, myrislignan, had a strong protective effect against liver damage.

SourceAmerican Chemical Society·JournalJournal of Proteome Research·DateMay 9, 2018